, 2014 本发明提供了一种MCM-49分子筛催化剂的改性方法，具体步骤如下：将含不同量模板剂（0.01～30wt%）的Na-型MCM-49分子筛用0.01～1.0mol/L的十六烷基三甲基溴化铵与0.01～2.0mol/L的氢氧化钠的混合溶液在20～100℃下处理10～150分钟，用盐酸调pH至6；得到的产物干燥、焙烧，用硝酸铵溶液交换，过滤，并用去离子水洗涤、干燥后，焙烧成H-型催化剂；本发明制备的改性的MCM-49分子筛催化剂，与未经过处理、或只采用十六烷基三甲基溴化铵或氢氧化钠溶液处理的MCM ...
徐龙伢 +8 more
core
[Novel targets and drugs for the treatment of portal hypertension in liver cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhu CP, Xie WF.
europepmc +1 more source
, 2010 本发明涉及一种农田中盐碱斑地的改良方法，该方法为在盐碱斑地内，先洗排盐碱，再躲盐巧种的步骤进行，即先在盐碱斑地中间固定由沙砾石、管壁带孔的水泥管、入水口、引水沟、集水槽、顶盖和闸门组成的旱井，在旱井的周围挖沟起垅，灌水、晾晒反复进行直到大部分盐碱地内的地表积盐大部分排入地下，然后在沟与垅之间的斜坡面上种植耐盐碱植物，待耐盐碱植物长大后，覆盖土面，不断灌水压盐碱，从而实现对农田中盐碱斑地的改良。本发明可以大面积综合利用盐碱地，扩大盐碱地植被覆盖面积 ...
王积强, 赵成义.
core
[Oral mucosal administration]. [PDF]
Hua Xi Kou Qiang Yi Xue Za ZhiLiu T, Liu J, Zhao H.
europepmc +1 more source
[Pathological characteristics, therapeutic strategies, and prognostic assessment in children with crescentic IgA vasculitis with nephritis]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiZhang QS +4 more
europepmc +1 more source
[Advances in Systemic Therapy for Extensive-stage Small Cell Lung Cancer in the Era of Precision Treatment]. [PDF]
Zhongguo Fei Ai Za ZhiChen H, Xu L, Cheng Y, Zhou L.
europepmc +1 more source
[Advances in growth impairment associated with pediatric respiratory diseases]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiChen XW, Chen DH.
europepmc +1 more source
[Multiple clinical effects of recombinant human growth hormone therapy]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiZhou B, Yang Y.
europepmc +1 more source
[Efficacy of the 3-month formulation of triptoreli in children with idiopathic central precocious puberty]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiYu K, Bei YH, Deng SL, Wang X.
europepmc +1 more source
[Buffering effect of intensive lipid lowering on mortality risk in type 2 diabetic patients with chronic kidney disease and challenging glycemic management: a cohort study based on dual metabolic trajectories]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoWang X, Yang J, Liang S, Dong Z.
europepmc +1 more source